Page 120 - MI-2-1

Microbes & Immunity Anti-mouse CXCR5 monoclonal antibody

A novel anti-mouse CXCR1 monoclonal antibody for flow 60. Available from: https://www.biolegend.com/ja-jp/products/
cytometry. Monoclon Antib Immunodiagn Immunother. purified-anti-mouse-cd185-cxcr5-antibody-8454 [Last
2024;43:59-66. accessed on 2024 May 10].
doi: 10.1089/mab.2023.0031 61. Hsieh CH, Jian CZ, Lin LI, et al. Potential role of CXCL13/
CXCR5 signaling in immune checkpoint inhibitor treatment
51. Tanaka T, Nanamiya R, Takei J, et al. Development of anti- in cancer. Cancers (Basel). 2022;14(2):294.
mouse CC chemokine receptor 8 monoclonal antibodies for
flow cytometry. Monoclon Antib Immunodiagn Immunother. doi: 10.3390/cancers14020294
2021;40(2):65-70. 62. Crotty S. Follicular helper CD4 T cells (TFH). Annu Rev
doi: 10.1089/mab.2021.0005 Immunol. 2011;29:621-663.
52. Gu X, Li D, Wu P, et al. Revisiting the CXCL13/CXCR5 doi: 10.1146/annurev-immunol-031210-101400
axis in the tumor microenvironment in the era of single- 63. Im SJ, Hashimoto M, Gerner MY, et al. Defining CD8+ T
cell omics: Implications for immunotherapy. Cancer Lett. cells that provide the proliferative burst after PD-1 therapy.
2024;605:217278. Nature. 2016;537(7620):417-421.
doi: 10.1016/j.canlet.2024.217278 doi: 10.1038/nature19330
53. Tanaka T, Li G, Asano T, et al. Development of a novel 64. Brummelman J, Mazza EMC, Alvisi G, et al. High-
anti-mouse CCR2 monoclonal antibody (C(2)Mab-6) dimensional single cell analysis identifies stem-like
by N-terminal peptide immunization. Monoclon Antib cytotoxic CD8(+) T cells infiltrating human tumors. J Exp
Immunodiagn Immunother. 2022;41(2):80-86. Med. 2018;215(10):2520-2535.
doi: 10.1089/mab.2021.0063 doi: 10.1084/jem.20180684
54. Asano T, Suzuki H, Goto N, et al. Establishment of novel 65. He R, Hou S, Liu C, et al. Follicular CXCR5- expressing
anti-mouse CCR3 monoclonal antibodies (C mab-6 and CD8(+) T cells curtail chronic viral infection. Nature.
3
C Mab-7) by N-terminal peptide immunization. Monoclon 2016;537(7620):412-428.
3
Antib Immunodiagn Immunother. 2022;41(2):94-100. doi: 10.1038/nature19317
doi: 10.1089/mab.2021.0065 66. Kallies A, Zehn D, Utzschneider DT. Precursor exhausted T
55. Takei J, Suzuki H, Asano T, et al. Development of a novel cells: Key to successful immunotherapy? Nat Rev Immunol.
anti-mouse CCR4 monoclonal antibody (C Mab-1) by 2020;20(2):128-136.
4
N-terminal peptide immunization. Monoclon Antib doi: 10.1038/s41577-019-0223-7
Immunodiagn Immunother. 2022;41(2):87-93.
67. Thommen DS, Koelzer VH, Herzig P, et al. A transcriptionally
doi: 10.1089/mab.2021.0064 and functionally distinct PD-1(+) CD8(+) T cell pool with
56. Asano T, Tanaka T, Suzuki H, et al. Development of a predictive potential in non-small-cell lung cancer treated
novel anti-mouse CCR6 monoclonal antibody (C Mab-13) with PD-1 blockade. Nat Med. 2018;24(7):994-1004.
6
by N-terminal peptide immunization. Monoclon Antib doi: 10.1038/s41591-018-0057-z
Immunodiagn Immunother. 2022;41(6):343-349.
68. De Chaisemartin L, Goc J, Damotte D, et al. Characterization
doi: 10.1089/mab.2022.0021 of chemokines and adhesion molecules associated with T
cell presence in tertiary lymphoid structures in human lung
57. Kobayashi H, Asano T, Suzuki H, et al. Establishment cancer. Cancer Res. 2011;71(20):6391-6399.
of a sensitive monoclonal antibody against mouse
CCR9 (C Mab-24) for flow cytometry. Monoclon Antib doi: 10.1158/0008-5472.Can-11-0952
9
Immunodiagn Immunother. 2023;42(1):15-21. 69. Mitkin NA, Hook CD, Schwartz AM, et al. p53-dependent
doi: 10.1089/mab.2022.0032 expression of CXCR5 chemokine receptor in MCF-7 breast
cancer cells. Sci Rep. 2015;5:9330.
58. Kitamura K, Suzuki H, Kaneko MK, Kato Y. Cx Mab-1:
6
A novel anti-mouse CXCR6 monoclonal antibody doi: 10.1038/srep09330
established by N-terminal peptide immunization. Monoclon 70. Mitkin NA, Muratova AM, Sharonov GV, et al. p63 and
Antib Immunodiagn Immunother. 2022;41(3):133-141. p73 repress CXCR5 chemokine receptor gene expression
doi: 10.1089/mab.2022.0010 in p53-deficient MCF-7 breast cancer cells during
genotoxic stress. Biochim Biophys Acta Gene Regul Mech.
59. Satofuka H, Suzuki H, Tanaka T, et al. A Novel Anti-mouse 2017;1860(12):1169-1178.
CCR7 Monoclonal Antibody, C7Mab-7, Demonstrates
High Sensitivity in Flow Cytometry, Western Blot, and doi: 10.1016/j.bbagrm.2017.10.003
Immunohistochemistry. [Preprints]; 2024. 71. Takei J, Kaneko MK, Ohishi T, et al. A defucosylated

Volume 2 Issue 1 (2025) 112 doi: 10.36922/mi.5664